Genetic Predictors of Long-Term Response to Growth Hormone (GH) Therapy in Children With GH Deficiency and Turner Syndrome: The Influence of a SOCS2 Polymorphism
Author(s) -
Adriana F. Braz,
Everlayny F. Costalonga,
Ericka Barbosa Trarbach,
Renata C. Scalco,
Alexsandra C. Malaquias,
Gil GuerraJúnior,
Sonir Roberto Rauber Antonini,
Berenice B. Mendonça,
Ivo J.P. Arnhold,
Alexander A.L. Jorge
Publication year - 2014
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2014-1744
Subject(s) - igfbp3 , growth hormone receptor , medicine , endocrinology , allele , socs2 , genotype , biology , single nucleotide polymorphism , exon , turner syndrome , genetics , receptor , gene , growth hormone , hormone , growth factor , cancer , suppressor
There is great interindividual variability in the response to GH therapy. Ascertaining genetic factors can improve the accuracy of growth response predictions. Suppressor of cytokine signaling (SOCS)-2 is an intracellular negative regulator of GH receptor (GHR) signaling.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom